In vitro activity of moxalactam alone and in combination with penicillin against common meningeal pathogens.
Moxalactam demonstrated marked activity against beta-lactamase-positive and -negative Haemophilus influenzae, Streptococcus pneumoniae, and Neisseria meningitidis by both standard minimal inhibitory concentration testing and growth curve studies. Moxalactam was ineffective against S. pneumoniae partially susceptible to penicillin G. Moxalactam (5 micrograms/ml) and penicillin (1 microgram/ml) in combination were indifferent to each other's antibacterial activity, exerting neither synergism nor antagonism against these organisms.
D001419:Bacteria / Q000187:drug effects*; D002511:Cephalosporins / Q000494:pharmacology*; D002513:Cephamycins / Q000494:pharmacology*; D004347:Drug Interactions; D006193:Haemophilus influenzae / Q000187:drug effects; D008581:Meningitis / Q000382:microbiology*; D008826:Microbial Sensitivity Tests; D009070:Moxalactam; D009345:Neisseria meningitidis / Q000187:drug effects; D010400:Penicillin G / Q000494:pharmacology*; D010403:Penicillin Resistance; D013296:Streptococcus pneumoniae / Q000187:drug effects
D002511:Cephalosporins; D002513:Cephamycins; D010400:Penicillin G; D009070:Moxalactam